Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DGX NYSE:DVA NYSE:LH NASDAQ:LHCG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDGXQuest Diagnostics$166.79-0.8%$174.95$137.71▼$182.38$18.77B0.491.00 million shs1.56 million shsDVADaVita$141.13-1.6%$140.11$131.76▼$179.60$10.83B1.11810,218 shs708,797 shsLHLabcorp$243.73-1.4%$253.65$205.98▼$265.72$20.69B0.82652,866 shs573,363 shsLHCGLHC Group$169.81$166.14$115.32▼$169.84$5.27B0.43576,665 shsN/A7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDGXQuest Diagnostics-0.88%-0.72%-7.15%+1.85%+12.28%DVADaVita-1.55%-0.91%+4.04%+0.66%+1.04%LHLabcorp-1.38%-2.21%-6.82%+12.19%+12.91%LHCGLHC Group0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDGXQuest Diagnostics4.9498 of 5 stars3.32.04.24.72.82.52.5DVADaVita4.4428 of 5 stars2.02.00.04.52.91.73.8LHLabcorp4.6144 of 5 stars3.32.02.54.22.52.51.3LHCGLHC GroupN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDGXQuest Diagnostics 2.69Moderate Buy$186.0711.56% UpsideDVADaVita 2.00Hold$164.5016.56% UpsideLHLabcorp 2.57Moderate Buy$276.0813.27% UpsideLHCGLHC Group 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest LHCG, LH, DGX, and DVA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/18/2025DGXQuest DiagnosticsUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$176.00 ➝ $175.007/18/2025LHLabcorpUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$284.00 ➝ $282.007/10/2025LHLabcorpHsbc Global ResSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold7/10/2025LHLabcorpHSBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$260.007/9/2025LHLabcorpEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$260.00 ➝ $285.006/25/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingCautious ➝ Cautious6/25/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$250.00 ➝ $275.006/11/2025LHLabcorpMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$270.00 ➝ $283.005/19/2025DVADaVitaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$170.00 ➝ $164.005/12/2025LHLabcorpTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$274.00 ➝ $290.005/6/2025LHLabcorpPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$260.00 ➝ $280.00(Data available from 7/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDGXQuest Diagnostics$9.87B1.89$13.40 per share12.45$61.38 per share2.72DVADaVita$12.82B0.83$18.84 per share7.49$4.83 per share29.22LHLabcorp$13.01B1.57$22.08 per share11.04$96.27 per share2.53LHCGLHC Group$2.22B2.37$7.51 per share22.60$52.17 per share3.25Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDGXQuest Diagnostics$871M$7.9121.0915.902.358.81%15.11%6.65%7/22/2025 (Estimated)DVADaVita$936.34M$10.0913.9911.100.996.63%176.11%4.66%8/5/2025 (Estimated)LHLabcorp$746M$8.6528.1813.901.575.55%15.27%6.97%7/24/2025 (Estimated)LHCGLHC Group$115.73M$2.0582.8335.2322.732.73%8.13%4.63%N/ALatest LHCG, LH, DGX, and DVA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025DVADaVita$2.70N/AN/AN/A$3.36 billionN/A7/24/2025Q2 2025LHLabcorp$4.12N/AN/AN/A$3.49 billionN/A7/22/2025Q2 2025DGXQuest Diagnostics$2.56N/AN/AN/A$2.73 billionN/A5/12/2025Q1 2025DVADaVita$1.75$2.00+$0.25$2.00$3.22 billion$3.22 billion4/29/2025Q1 2025LHLabcorp$3.73$3.84+$0.11$2.52$3.41 billion$3.35 billion4/22/2025Q1 2025DGXQuest Diagnostics$2.15$2.21+$0.06$1.94$2.63 billion$2.65 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDGXQuest Diagnostics$3.201.92%N/A40.46%14 YearsDVADaVitaN/AN/AN/AN/AN/ALHLabcorp$2.881.18%N/A33.29%N/ALHCGLHC GroupN/AN/AN/AN/AN/ALatest LHCG, LH, DGX, and DVA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/10/2025LHLabcorpquarterly$0.721.11%8/28/20259/11/20255/14/2025DGXQuest Diagnosticsquarterly$0.801.86%7/7/20257/7/20257/21/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDGXQuest Diagnostics0.841.441.31DVADaVita23.181.251.20LHLabcorp0.681.841.60LHCGLHC Group0.441.451.45Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDGXQuest Diagnostics88.06%DVADaVita90.12%LHLabcorp95.94%LHCGLHC Group83.47%Insider OwnershipCompanyInsider OwnershipDGXQuest Diagnostics8.16%DVADaVita2.00%LHLabcorp0.84%LHCGLHC Group4.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDGXQuest Diagnostics56,000111.64 million102.53 millionOptionableDVADaVita76,00075.50 million73.99 millionOptionableLHLabcorp70,00083.70 million83.00 millionOptionableLHCGLHC Group30,00031.03 million29.54 millionOptionableLHCG, LH, DGX, and DVA HeadlinesRecent News About These CompaniesOptum, LHC Group Put Pedal Down On Home-Based Care EffortsDecember 5, 2024 | homehealthcarenews.comH3 Stocks Raising Dividends 4X Higher Than InflationSeptember 26, 2024 | finance.yahoo.comLHC orders removal of Nadra chairman citing ‘unauthorized appointment’September 8, 2024 | dawn.comDLHC orders removal of Nadra chairman citing ‘unauthorised appointment’September 8, 2024 | dawn.comDAccelerator report: LHC run 3 achieves record-breaking integrated luminositySeptember 4, 2024 | phys.orgPNew Constraints on Magnetic Monopoles from LHC ExperimentAugust 21, 2024 | msn.comNext-generation triggers for HL-LHC and beyondMay 3, 2024 | cerncourier.comCOne of Cettire’s most prominent backers has sold out entirelyApril 23, 2024 | afr.comLHC sentences lawyer to 6 months in jail for misbehaving with judgeApril 10, 2024 | dawn.comDLife Healthcare Group Holdings Ltd.February 17, 2024 | wsj.comJustice Anwaarul Haq takes oath as Chief Justice LHCJuly 31, 2023 | radio.gov.pkRUnitedHealth offers over $3 bln for home health firm AmedisysJune 5, 2023 | reuters.comJustice Muhammad Ameer Bhatti takes oath as new Chief Justice of LHCMay 27, 2023 | radio.gov.pkRLHC stops former Punjab CM Buzdar’s arrest till ThursdayMay 5, 2023 | tribune.com.pkTWhat will the Large Hadron Collider discover next?April 27, 2023 | bbc.co.ukLHC Group Stock Hits New 52-Week Low (LHCG)April 17, 2023 | thestreet.comAfter Closing On LHC Group Deal, Optum Looks To Capitalize On Home-Based Care CapabilitiesApril 15, 2023 | homehealthcarenews.comHConstruction framework provider LHC Procurement Group reinforces foundations with two key Scottish hiresApril 10, 2023 | scotsman.comSLHC Group 'more valuable' being in Lafayette in merger with UnitedHealth, co-founder saysApril 6, 2023 | theadvocate.comTLHC strikes down colonial-era sedition law that stifled free speechApril 1, 2023 | pakistantoday.com.pkPNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack ModeLHCG, LH, DGX, and DVA Company DescriptionsQuest Diagnostics NYSE:DGX$166.79 -1.39 (-0.83%) Closing price 07/18/2025 03:59 PM EasternExtended Trading$166.20 -0.58 (-0.35%) As of 07/18/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$141.13 -2.25 (-1.57%) Closing price 07/18/2025 03:59 PM EasternExtended Trading$141.16 +0.03 (+0.02%) As of 07/18/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Labcorp NYSE:LH$243.73 -3.51 (-1.42%) Closing price 07/18/2025 03:59 PM EasternExtended Trading$243.18 -0.55 (-0.23%) As of 07/18/2025 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.LHC Group NASDAQ:LHCGLHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations. The Home Health segment offers a wide range of services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education. The Hospice Services segment offer a wide range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The Home & Community-Based Services segment are performed by paraprofessional personnel, and include assistance to the elderly, chronically ill, and disabled patients with activities of daily living. The Facility Based Services segment includes long-term acute care hospitals treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical perso More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era How Goldman Sachs Earnings Help You Strategize Your Portfolio Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
